UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
This guide highlights the most trusted stablecoins based on reserves, audits, and transparency to help you choose confidently.
19,370 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A rapid AI-driven capex cycle is widening the performance split between cap-weighted and equal-weight NASDAQ funds, u...
Baby Boomers carry a wide mix of home equity, retirement savings, and debt. This guide explains what the average Boom...
TJX delivered a solid quarter, lifting confidence in a consumer-driven recovery. This analysis dives into whether com...
A fresh look at history shows disciplined buyers beat market timers over lengthy, stagnant periods. The counterintuit...
When policymakers hint at rate moves, investors scramble to reprice risk. This guide breaks down how an evolving inte...
U.S. gasoline stocks have fallen for 14 consecutive weeks, pushing Memorial Day prices toward four-year highs as WTI ...
Meta Platforms sits at the intersection of massive user reach and smart monetization work. This piece explains why it...
Agora's API-driven platform powers live video, voice, and real-time engagement for apps worldwide. This deep dive exa...
People are embracing relaxed, outdoor-centered living. This article explores how casual nights outdoor spaces are cha...
Celebrity headlines often miss the money side of family planning. This article breaks down the costs, contracts, and ...
OpenAI’s growing power needs are drawing attention to a little-known Michigan utility tied to a major data-center dea...